APOTHEEK ROOSEN
0430.444.725 · rovalta.com · 25/09/2026
ACTIVE
APOTHEEK ROOSEN
Financial year 2025 · Closed on 31/12/2025
Net result111 k €-21,5 %over 1 year
Gross margin330,1 k €-6,1 %over 1 year
Equity824,5 k €+15,6 %over 1 year
Workforce1,8 ETP0,0 %over 1 year
Overview
Identity
Source · BCE/KBOAPOTHEEK ROOSEN is a Private limited company incorporated in 1987. Its registered office is in Genk. It employs on average 1,8 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0430.444.725
- Incorporation
- 04/02/1987
- Legal form
- Private limited company
- Registered office
- Sledderlo 50
3600 Genk · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 1,8 ETP
Joint committees (2)
- 313
- 31300
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Financials
Source · NBB, 20 filingsTrend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 330,1 k € | -6.1% | 351,6 k € | +15.3% | 304,9 k € | -14.7% | 357,4 k € | +10.1% | 324,5 k € |
| EBITDA | 195,3 k € | -16.2% | 233,1 k € | +24.4% | 187,5 k € | -26.9% | 256,4 k € | +12.4% | 228,1 k € |
| Operating result | 154 k € | -25.5% | 206,7 k € | +25.5% | 164,7 k € | -29.8% | 234,6 k € | +9.8% | 213,8 k € |
| Net result | 111 k € | -21.5% | 141,4 k € | +28.3% | 110,2 k € | -23.2% | 143,6 k € | -10.7% | 160,7 k € |
| Balance sheet | |||||||||
| Equity | 824,5 k € | +15.6% | 713,5 k € | +13.0% | 631,5 k € | +11.3% | 567,6 k € | +18.7% | 478,2 k € |
| Total assets | 1,3 M € | +53.5% | 847,5 k € | +7.5% | 788,3 k € | +1.6% | 775,7 k € | -1.8% | 790 k € |
| Cash | 327,7 k € | +14.6% | 286 k € | -36.0% | 447,1 k € | -5.1% | 471,2 k € | -6.0% | 501,3 k € |
| Debts | 470,4 k € | +282% | 123,3 k € | +22.3% | 100,8 k € | -51.0% | 206 k € | -30.0% | 294,3 k € |
| Other | |||||||||
| Workforce | 1,8 ETP | 0.0% | 1,8 ETP | 0.0% | 1,8 ETP | +5.9% | 1,7 ETP | 0.0% | 1,7 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20253 active · 9 ended
Active mandates
Myriam Roosen
ActiveNicolas Meuwissen
ActivePaul Meuwissen
ActiveEnded mandates
Myriam Roosen
EndedMyriam Roosen
EndedMyriam Roosen
EndedNicolas Meuwissen
EndedFinancials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 11/05/2026 | 04/06/2025 | 11/08/2024 | 28/08/2023 | 28/07/2022 | 19/08/2021 |
| General meeting | 09/05/2026 | 11/05/2025 | 11/05/2024 | 13/05/2023 | 14/05/2022 | 08/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 09/05/2026 | 11/05/2026 | Dutch | |
| Abridged model | 31/12/2024 | 11/05/2025 | 04/06/2025 | Dutch | |
| Abridged model | 31/12/2023 | 11/05/2024 | 11/08/2024 | Dutch | |
| Abridged model | 31/12/2022 | 13/05/2023 | 28/08/2023 | Dutch | |
| Abridged model | 31/12/2021 | 14/05/2022 | 28/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 08/05/2021 | 19/08/2021 | Dutch | |
| Abridged model | 31/12/2019 | 31/08/2020 | 30/09/2020 | Dutch | |
| Abridged model | 31/12/2018 | 29/06/2019 | 29/08/2019 | Dutch | |
| Abridged model | 31/12/2017 | 12/05/2018 | 31/08/2018 | Dutch | |
| Abridged model | 31/12/2016 | 30/06/2017 | 10/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 30/06/2016 | 31/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 30/06/2015 | 31/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 30/06/2014 | 22/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 30/06/2013 | 29/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 23/06/2012 | 04/07/2012 | Dutch | |
| Abridged model | 31/12/2010 | 04/06/2011 | 28/06/2011 | Dutch | |
| Abridged model | 31/12/2009 | 29/05/2010 | 16/06/2010 | Dutch | |
| Abridged model | 31/12/2008 | 09/05/2009 | 28/05/2009 | Dutch | |
| Abridged model | 31/12/2007 | 10/05/2008 | 05/06/2008 | Dutch | |
| Abridged model | 31/12/2006 | 12/05/2007 | 29/05/2007 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20253 active · 9 ended
Active mandates
Myriam Roosen
ActiveNicolas Meuwissen
ActivePaul Meuwissen
ActiveEnded mandates
Myriam Roosen
EndedMyriam Roosen
EndedMyriam Roosen
EndedNicolas Meuwissen
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates21/11/2022STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - BENAMING - DOEL - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
- Capital / shares24/01/2018Kapitaalvermindering
- Mandates28/03/2017BENOEMING ZAAKVOERDER
- Capital / shares08/01/2014Kapitaalverhoging
- Mandates06/01/2010KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025111 k €↓
- 2024Annual accounts 2024141,4 k €↑
- 2023Annual accounts 2023110,2 k €↓
- 2022Annual accounts 2022143,6 k €↓
- 2022Name changeAPOTHEEK ROOSEN
- 2021Annual accounts 2021160,7 k €↑
- 2021Name changeApoteek Roosen
- 2020Annual accounts 202069,4 k €↑
- 2019Annual accounts 201967 k €↑
- 2018Annual accounts 201848,4 k €↑
- 2017Annual accounts 201746,3 k €↓
- 2016Annual accounts 201654,1 k €↑
- 2015Annual accounts 201552,1 k €↑
- 2014Annual accounts 201440,8 k €↑
- 2013Annual accounts 201314,6 k €↓
- 2012Annual accounts 201218,5 k €↑
- 2011Annual accounts 201116,7 k €↓
- 2010Annual accounts 201017,1 k €↓
- 2009Annual accounts 200930,3 k €↑
- 2008Annual accounts 200811,6 k €↓
- 2007Annual accounts 200714,5 k €↑
- 2006Annual accounts 20068,2 k €
- 04/02/1987IncorporationPrivate limited company